Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Osteoprotegerin: new polypeptide for bone diseases

Sep. 9, 1997

Voglibose preclinical results described at Japanese congress

Sep. 8, 1997

Genentech discontinues IGF-I development for type I and II diabetes

Sep. 8, 1997

GH secretagogues claimed by Novo Nordisk

Sep. 8, 1997

Sequana and Glaxo Wellcome near discovery of diabetes genes

Sep. 8, 1997

ENDOcare's device for abnormal uterine bleeding enters clinical trials

Sep. 8, 1997

Vertex and Alpha Therapeutic end hemoglobin collaboration

Sep. 4, 1997

Long-term U.S. clinical trial results for orlistat reported in Stockholm

Sep. 3, 1997

Pfizer identifies potent cholesterol absorption inhibitors

Sep. 3, 1997

Crinone launched in the U.S.

Sep. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...